About Sysmex
Sysmex is a company based in Japan founded in 1968. The company has 10,530 employees as of March 31, 2024. Sysmex has completed 1 acquisition, including Oxford Gene Technology. Sysmex operates in a competitive market with competitors including Roche, Cepheid, Esco Lifesciences, Beckman Coulter and Blackrock Neurotech, among others.
- Headquarter Hyogo, Japan
- Employees 10530 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sysmex Corporation
-
Annual Revenue
$3.4 B (USD)10.21as on Mar 31, 2025
-
Net Profit
$359.16 M (USD)8.12as on Mar 31, 2025
-
EBITDA
$861.33 M (USD)13.71as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
10530
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sysmex
Sysmex is a publicly listed company on the TSE with ticker symbol 6869 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Sysmex
Unlock access to complete
Funding Insights of Sysmex
Detailed funding history for Sysmex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sysmex
Sysmex has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Oxford Gene Technology.
Investment portfolio details for Sysmex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genetics research and biomarker solutions are provided to research institutions.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Sysmex
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sysmex
Detailed financials for Sysmex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sysmex Comparisons
Peer comparison for Sysmex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sysmex
Sysmex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Cepheid, Esco Lifesciences, Beckman Coulter and Blackrock Neurotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Provider of laboratory management system for researchers and clinicians
|
Detailed competitors of Sysmex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sysmex
Complete news archive for Sysmex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sysmex
Sysmex was founded in 1968.
Sysmex is headquartered in Japan. It is registered at Hyogo, Japan.
Hisashi Letsugu is the current CEO of Sysmex.
As of Mar 31, 2024, the latest employee count at Sysmex is 10,530.
Annual revenue of Sysmex is $3.4B as on Mar 31, 2025.
Developer of diagnostic instruments, reagents, and related software. The company offers a range of diagnostic instruments and solutions across various fields, including hematology, urinalysis, hemostasis, flow cytometry, and life science.
Sysmex's top competitors include Cepheid, Roche and Blackrock Neurotech.
Yes, Sysmex is publicly traded on TSE under the ticker symbol 6869.
Sysmex has made 1 acquisition, including Oxford Gene Technology.
The ticker symbol of Sysmex is 6869 on TSE.